Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri

Oncology Reports

Volumn 22, Issue 5, 2009, Pages 1129-1134

  Feng, Dingqing ^a   Peng, Cheng ^a   Li, Cairong ^a   Zhou, Ying ^a   Li, Min ^a   Ling, Bin ^a   Wei, Haiming ^b   Tian, Zhigang ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Cancer stem cell; CD44; Cervical cancer; CK17

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CK17 ANTIGEN; DOXORUBICIN; GENE PRODUCT; HERMES ANTIGEN; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PACLITAXEL; PROTEIN PIWIL2; STAT3 PROTEIN; TRANSCRIPTION FACTOR SOX2; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER RESISTANCE; CANCER STAGING; CANCER STEM CELL; CARCINOGENICITY; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT; UTERINE CERVIX CARCINOMA; WESTERN BLOTTING;

ADULT; ANIMALS; ANTIGENS, CD44; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE MODELS, ANIMAL; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; IMINES; IMMUNOENZYME TECHNIQUES; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; PACLITAXEL; SPHEROIDS, CELLULAR; THIAZINES; UTERINE CERVICAL NEOPLASMS;

EID: 70449366086     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000545     Document Type: Article

References (36)

1. Ferenczy A and Franco E: Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 3: 11-16, 2002.
2. Tjalma WA, Van Waes TR, Van den Eeden LE and Bogers JJ: Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best Pract Res Clin Obstet Gynaecol 19: 469-483, 2005.
3. Werness BA, Levine AJ and Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79, 1990.
4. Nindl I, Rindfleisch K, Lotz B, Schneider A and Durst M: Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int J Cancer 82: 203-207, 1999.
5. Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 414: 105-111, 2001.
6. Marx J: Cancer research. Mutant stem cells may seed cancer. Science 301: 1308-1310, 2003.
7. Pardal R, Clarke MF and Morrison SJ: Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3: 895-902, 2003.
8. Matsui W, Huff CA, Wang Q, et al: Characterization of clonogenic multiple myeloma cells. Blood 103: 2332-2336, 2004.
9. Hirschmann-Jax C, Foster AE, Wulf GG, et al: A distinct 'side population' of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101: 14228-14233, 2004.
10. Kondo T, Setoguchi T and Taga T: Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 101: 781-786, 2004.
11. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003.
12. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, et al: Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci USA 103: 11154-11159, 2006.
13. Friel AM, Sergent PA, Patnaude C, et al: Functional analyses of the cancer stem cell-like properties of human endometrial tumor initiating cells. Cell Cycle 7: 242-249, 2008.
14. Collins AT, Berry PA, Hyde C, Stower MJ and Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951, 2005.
15. Singh SK, Hawkins C, Clarke ID, et al: Identification of human brain tumour initiating cells. Nature 432: 396-401, 2004.
16. Ho MM, Ng AV, Lam S and Hung JY: Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67: 4827-4833, 2007.
17. Zhang S, Balch C, Chan MW, et al: Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68: 4311-4320, 2008.
18. Ponti D, Costa A, Zaffaroni N, et al: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65: 5506-5511, 2005.
19. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ and Wicha MS: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253-1270, 2003.
20. Prince ME, Sivanandan R, Kaczorowski A, et al: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104: 973-978, 2007.
21. Martens JE, Arends J, Van der Linden PJ, De Boer BA and Helmerhorst TJ: Cytokeratin 17 and p63 are markers of the HPV target cell, the cervical stem cell. Anticancer Res 24: 771-775, 2004.
22. Regauer S and Reich O: CK17 and p16 expression patterns distinguish (atypical) immature squamous metaplasia from high-grade cervical intraepithelial neoplasia (CIN III). Histopathology 50: 629-635, 2007.
23. Li L and Neaves WB: Normal stem cells and cancer stem cells: the niche matters. Cancer Res 66: 4553-4557, 2006.
24. Koestenbauer S, Zech NH, Juch H, Vanderzwalmen P, Schoonjans L and Dohr G: Embryonic stem cells: similarities and differences between human and murine embryonic stem cells. Am J Reprod Immunol 55: 169-180, 2006.
25. Cox DN, Chao A, Baker J, Chang L, Qiao D and Lin H: A novel class of evolutionarily conserved genes defined by piwi are essential for stem cell self-renewal. Genes Dev 12: 3715-3727, 1998.
26. Kuramochi-Miyagawa S, Kimura T, Ijiri TW, et al: Mili, a mammalian member of piwi family gene, is essential for spermatogenesis. Development 131: 839-849, 2004.
27. Carmell MA, Xuan Z, Zhang MQ and Hannon GJ: The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis. Genes Dev 16: 2733-2742, 2002.
28. Chambers I and Smith A: Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 23: 7150-7160, 2004.
29. Lee JH, Schutte D, Wulf G, et al: Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Hum Mol Genet 15: 201-211, 2006.
30. Wei C, Guomin W, Yujun L and Ruizhe Q: Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line? Cancer Biol Ther 6: 763-768, 2007.
31. Dean M, Fojo T and Bates S: Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275-284, 2005.
32. Doyle LA and Ross DD: Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22: 7340-7358, 2003.
33. Bao S, Wu Q, Sathornsumetee S, et al: Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66: 7843-7848, 2006.
34. Shen R, Ye Y, Chen L, Yan Q, Barsky SH and Gao JX: Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS ONE 3: e1652, 2008.
35. Gao JX: Cancer stem cells: the lessons from pre-cancerous stem cells. J Cell Mol Med 12: 67-96, 2008.
36. Medina MA, Munoz-Chapuli R and Quesada AR: Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope. J Cell Mol Med 11: 374-382, 2007.